This combination treatment resulted in increased overall survival of MC38-CEA tumor-bearing mice (Figure 2c), extending survival from 28 days in untreated controls to 49.5 days in animals treated with αTIGIT + bintrafusp alfa (p = .0227; Figure 2c). The gene discussed is CEACAM5; the disease is neoplasm.